State Street’s KALA BIO KALA Stock Holding History

State Street’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$153K	Buy	88,570 +87,998	+15,384%	+$427K	﹤0.01%	3964
2026 Q1	$4.95K	Hold	572	–	–	﹤0.01%	4260
2025 Q4	$15.9K	Hold	572	–	–	﹤0.01%	4255
2025 Q3	$43.7K	Buy	+572	New	+$284K	﹤0.01%	4172
2023 Q1	–	Sell	-200	Closed	-$381K	–	4804
2022 Q4	$381K	Buy	200 +154	+335%	+$61K	﹤0.01%	3861
2022 Q3	$25K	Sell	46 -59	-56%	-$46.3K	﹤0.01%	4792
2022 Q2	$79K	Sell	105 -385	-79%	-$604K	﹤0.01%	4609
2022 Q1	$1.69M	Buy	490 +43	+10%	+$113K	﹤0.01%	3635
2021 Q4	$1.35M	Buy	447 +2	+0.4%	+$9.28K	﹤0.01%	3744
2021 Q3	$2.91M	Buy	445 +116	+35%	+$1M	﹤0.01%	3507
2021 Q2	$4.36M	Buy	329 +49	+18%	+$770K	﹤0.01%	3314
2021 Q1	$4.72M	Sell	280 -7	-2%	-$137K	﹤0.01%	3075
2020 Q4	$4.87M	Sell	287 -10	-3%	-$188K	﹤0.01%	2971
2020 Q3	$5.56M	Hold	297	–	–	﹤0.01%	2727
2020 Q2	$7.8M	Buy	297 +125	+73%	+$3.54M	﹤0.01%	2553
2020 Q1	$3.77M	Buy	172 +27	+19%	+$431K	﹤0.01%	2767
2019 Q4	$1.34M	Buy	145 +16	+12%	+$155K	﹤0.01%	3359
2019 Q3	$1.23M	Buy	129 +23	+22%	+$280K	﹤0.01%	3360
2019 Q2	$1.7M	Buy	106 +17	+19%	+$282K	﹤0.01%	3298
2019 Q1	$1.84M	Buy	89 +8	+10%	+$142K	﹤0.01%	3183
2018 Q4	$993K	Buy	81 +3	+4%	+$52K	﹤0.01%	3330
2018 Q3	$1.93M	Buy	78 +1	+1%	+$30.5K	﹤0.01%	3257
2018 Q2	$2.65M	Sell	77 -4	-5%	-$153K	﹤0.01%	3142
2018 Q1	$3.21M	Buy	81 +48	+145%	+$1.82M	﹤0.01%	2985
2017 Q4	$1.55M	Buy	33 +10	+43%	+$468K	﹤0.01%	3259
2017 Q3	$1.29M	Buy	+23	New	+$1.26M	﹤0.01%	3327

Other funds holding KALA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

State Street's KALA Position: Q2 2026 in Review

State Street increased its KALA BIO (KALA) stake by 15,384% in Q2 2026, buying an estimated $427K and bringing the position to 88,570 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #3964.

State Street first reported a position in KALA in Q3 2017 and has held it in 26 quarters since. The position peaked at $7.8M in Q2 2020. 15 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

State Street held 88,570 shares of KALA BIO worth $153K as of Q2 2026.
State Street bought 87,998 KALA BIO shares in Q2 2026, an estimated $427K.
KALA BIO made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3964 holding.
State Street first reported a position in KALA BIO in Q3 2017 and has held it in 26 quarters since.
State Street's KALA BIO position peaked at $7.8M in Q2 2020.
15 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.